Author Witzens-Harig, Mathias

• 2012 | Conference Abstract
  ​ ​Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))​
  Herfarth, K.; Engelhard, M.; Borchmann, P.; Hohloch, K.; Budach, V.; Viardot, A. & Witzens-Harig, M. et al.​ (2012)
  Blood, 120(21) , Atlanta, GA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2014 | Journal Article
  ​ ​Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group​
  Pfreundschuh, M.; Poeschel, V.; Zeynalova, S.; Haenel, M.; Held, G.; Schmitz, N. & Viardot, A. et al.​ (2014) 
  Journal of Clinical Oncology, 32(36) pp. 4127​-U354​.​ DOI: https://doi.org/10.1200/JCO.2013.54.6861 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article
  ​ ​Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL​
  Murawski, N.; Pfreundschuh, M.; Zeynalova, S.; Poeschel, V.; Haenel, M.; Held, G. & Schmitz, N. et al.​ (2014) 
  Annals of Oncology, 25(9) pp. 1800​-1806​.​ DOI: https://doi.org/10.1093/annonc/mdu208 
  ​Details  DOI  PMID  PMC  WoS 

• 2018 | Journal Article
  ​ ​Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA.​
  Pfreundschuh, M.; Murawski, N.; Ziepert, M.; Altmann, B.; Dreyling, M. H.; Borchmann, P. & Luminari, S. et al.​ (2018) 
  Journal of Clinical Oncology, 36(15_suppl) pp. 7574​-7574​.​ DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.7574 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA​
  Poeschel, V.; Held, G.; Ziepert, M.; Altmann, B.; Witzens-Harig, M.; Holte, H. & Thurner, L. et al.​ (2018) 
  Blood, 132(Supplement 1) pp. 781​-781​.​ DOI: https://doi.org/10.1182/blood-2018-99-112403 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial​
  Poeschel, V.; Held, G.; Ziepert, M.; Witzens-Harig, M.; Holte, H.; Thurner, L. & Borchmann, P. et al.​ (2019) 
  The Lancet, 394(10216) pp. 2271​-2281​.​ DOI: https://doi.org/10.1016/S0140-6736(19)33008-9 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial​
  König, L.; Dreyling, M.; Dürig, J.; Engelhard, M.; Hohloch, K. ; Viardot, A. & Witzens-Harig, M. et al.​ (2019) 
  Trials, 20(1).​ DOI: https://doi.org/10.1186/s13063-019-3614-y 
  ​Details  DOI 

• 2021 | Journal Article
  ​ ​Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial​
  Kaddu-Mulindwa, D.; Lesan, V.; Berdel, C.; Stilgenbauer, S.; Bewarder, M.; Thurner, L. & Witzens-Harig, M. et al.​ (2021) 
  Leukemia & Lymphoma, pp. 1​-9​.​ DOI: https://doi.org/10.1080/10428194.2021.1975193 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial​
  Braulke, F.; Zettl, F.; Ziepert, M.; Viardot, A.; Kahl, C.; Prange-Krex, G. & Korfel, A. et al.​ (2022) 
  HemaSphere, 6(12) art. e808​.​ DOI: https://doi.org/10.1097/HS9.0000000000000808 
  ​Details  DOI  WoS 

• 2023 | Journal Article
  ​ ​Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study​
  Thurner, L.; Ziepert, M.; Berdel, C.; Schmidt, C.; Borchmann, P.; Kaddu-Mulindwa, D. & Viardot, A. et al.​ (2023) 
  HemaSphere, 7(7) art. e904​.​ DOI: https://doi.org/10.1097/HS9.0000000000000904 
  ​Details  DOI 

Researcher

Sort

Items per Page